The Latest: Pfizer seeks FDA OK for vaccine booster dose
NEW YORK — Pfizer is seeking U.S. approval of a booster dose of its two-shot COVID-19 vaccine. The drugmaker announced Wednesday it has started the approval process for a third dose of its vaccine for Americans ages 16 and older. T...
